Newsfeeds - Spark Newswire

4 minute read

Acer Therapeutics Announces University Of North Carolina Receives $3M Department Of Defense Grant To Support The Proposed Investigator Sponsored OASIS Trial Of ACER-801 To Reduce the Frequency And Severity Of Post-Traumatic Stress Disorder

Today, 3:54 AM

$3 million awarded to University of North Carolina (UNC) to support a proposed 180-patient, randomized, placebo-controlled trial in trauma patients Proposed investigator sponsored trial to evaluate the

ACER

1 minute read

Acer Therapeutics Expands ACER-801 Development Into Post-Traumatic Stress Disorder

By Vandana Singh

Today, 3:54 AM

Acer Therapeutics Inc (NASDAQ:ACER) expanded ACER-801 (osanetant) into a new indication for the reduction of the frequency and severity of acute…

ACER

4 minute read

Acer Therapeutics Announces Expansion Of ACER-801 Development Indications To Include Post-Traumatic Stress Disorder

By Benzinga Newsdesk

Today, 3:54 AM

Licensed exclusive worldwide rights from Emory University to patents and patent applications for certain methods of treating or preventing post-traumatic stress disorder (PTSD) with osanetant Osanetant targets a

ACER

2 minute read

Recap Of Friday’s Biotech Catalysts – End Of the Day Summary

By Ragothaman Srinivasan

Today, 3:54 AM

Pfizer (NYSE:PFE) announced positive top-line results from its pivotal U.S. Phase 3 study in infants evaluating its 20-valent…

ACER

1 minute read

Relief And Acer Therapeutics Secures Orphan Drug Designation From European Union For Metabolic Disorder Candidate

By Ragothaman Srinivasan

Today, 3:54 AM

The European Commission has granted orphan medicinal product designation in the EU to Relief Therapeutics and Acer Therapeutics’ (NASDAQ: ACER) lead asset ACER-001 (sodium phenylbutyrate) for the potential treatment of patients with Maple Syrup Urine Disease (MSUD).

ACER

3 minute read

Recap Of Thursday’s Biotech Catalysts – End of The Day Summary

By Ragothaman Srinivasan

Today, 3:54 AM

Cyclerion Therapeutics (NASDAQ:CYCN) announced positive topline data from its clinical study of CY6463 for the treatment of Cognitive…

ACER

3 minute read

Daily Biotech Pulse: GSK’s Kidney Disease Drug Approved For Children, Tonix Pharma To Launch Monkeypox Vaccine Study In Kenya, Positive Effect Of Cyclerion’s Schizophrenia Candidate

By Vandana Singh

Today, 3:54 AM

Here's a roundup of top developments in the biotech space over the last 24 hours:

ABBV

3 minute read

Recap of Monday’s Biotech Catalysts – End of the Day Summary

By Ragothaman Srinivasan

Today, 3:54 AM

Abbvie (NYSE: ABBV) has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for atogepant for the prophylaxis of migraine in adult patients who have at least four migraine days per month.

ABBV

5 minute read

Tesla, Twitter And 76 Biggest Movers From Friday

By Lisa Levin

Today, 3:54 AM

Gainers Seritage Growth Properties (NYSE: SRG) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board recommended shareholders to approve a proposed plan sale.

ABEO

1 minute read

Here’s Why Acer Therapeutics Shares Are Moving

By Henry Khederian

Today, 3:54 AM

Acer Therapeutics Inc (NASDAQ: ACER) shares are trading higher by 7.43% to $1.52 after the company and Relief Therapeutics announced the CNIPA issued a utility model patent covering dosage form claims related to ACER-001's polymer-coated formulation.

ACER